Use of DNA Tests for Human Papillomavirus Infection by US Clinicians, 2004
| Autor: | Crystal Freeman, Kathleen L. Irwin, Linda Carlin, Danuta Kasprzyk, Daniel E. Montaño, Nidhi Jain |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male Health Knowledge Attitudes Practice medicine.medical_specialty Health Personnel MEDLINE Psychological intervention Genital warts Surveys and Questionnaires medicine Humans Immunology and Allergy Papillomaviridae Human papillomavirus Gynecology biology Cervical cytology screening Obstetrics business.industry Papillomavirus Infections HPV infection virus diseases Middle Aged biology.organism_classification medicine.disease United States female genital diseases and pregnancy complications Hpv testing Infectious Diseases Molecular Diagnostic Techniques Health Care Surveys DNA Viral Female business |
| Zdroj: | The Journal of Infectious Diseases. 196:76-81 |
| ISSN: | 1537-6613 0022-1899 |
| Popis: | Since 1999, human papillomavirus (HPV) DNA tests have been approved only for abnormal cervical cytology management and as an adjunct to cervical cytology screening. To assess HPV DNA testing practices, we mailed surveys to 6906 randomly selected clinicians in mid-2004. Awareness (87%) and ever use (67%) of HPV DNA tests was high. Test users were more likely than nonusers to be obstetricians/gynecologists or midwives, to be female, and to serve mainly privately insured patients. Respondents reported ever using HPV DNA tests for both approved and nonapproved indications, which included testing for HPV infection in women with anogenital warts or other sexually transmitted diseases, in their sex partners, and in men. Interventions are needed to discourage HPV DNA test use for nonapproved indications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|